Detalles de la búsqueda
1.
Effects of adoptive T-cell immunotherapy on immune cell profiles and prognosis of patients with unresectable or recurrent cholangiocarcinoma.
Int J Cancer
; 154(4): 738-747, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676069
2.
Prospective study of adoptive activated αßT lymphocyte immunotherapy for refractory cancers: development and validation of a response scoring system.
Cytotherapy
; 25(1): 76-81, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36253253
3.
Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG).
Cytotherapy
; 25(11): 1229-1235, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37486281
4.
Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic cancer.
Cytotherapy
; 23(2): 137-145, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32907781
5.
Identification of prognostic factors for γδT cell immunotherapy in patients with solid tumor.
Cytotherapy
; 22(6): 329-336, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303429
6.
A pilot study on the safety and efficacy of neoadjuvant chemoadoptive immunotherapy for locally advanced rectal cancer.
Oncol Lett
; 27(3): 101, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38298433
7.
Extended survival observed in adoptive activated T lymphocyte immunotherapy for advanced lung cancer: results of a multicenter historical cohort study.
Cancer Immunol Immunother
; 61(10): 1781-90, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22422103
8.
Efficacy of Adjuvant Immune-cell Therapy Combined With Systemic Therapy for Solid Tumors.
Anticancer Res
; 42(8): 4179-4187, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35896218
9.
Immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell therapy without antecedent surgery for advanced cancers.
Cancer Immunol Immunother
; 60(10): 1397-403, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21638124
10.
Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors.
Cytotherapy
; 13(1): 92-7, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20831354
11.
Prognostic Factors for Advanced/Recurrent Breast Cancer Treated With Immune-cell Therapy.
Anticancer Res
; 41(8): 4133-4141, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34281884
12.
Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports.
J Med Case Rep
; 15(1): 191, 2021 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33827668
13.
Prognostic Factors for Endometrial and Cervical Cancers of Uterus Treated With Immune-cell Therapy: A Retrospective Study.
Anticancer Res
; 40(8): 4729-4740, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32727799
14.
Adoptive Immune-Cell Therapy for the Treatment of Neuroendocrine Carcinoma of the Uterine Cervix.
Anticancer Res
; 40(8): 4741-4748, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32727800
15.
Effects of adaptive immune cell therapy on the immune cell profile in patients with advanced gastric cancer.
Cancer Med
; 9(14): 4907-4917, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32529780
16.
Changes in Immunological Status in Patients With Metastatic Colorectal Cancer Treated With First-line Chemoimmunotherapy.
Anticancer Res
; 40(8): 4763-4771, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32727803
17.
Significant clinical response of advanced colorectal cancer to combination therapy involving capecitabine and adoptive cell transfer therapy: a case report.
Transl Cancer Res
; 8(2): 693-698, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35116802
18.
Prognostic Factors for Colorectal Cancer Patients Treated With Combination of Immune-cell Therapy and First-line Chemotherapy: A Retrospective Study.
Anticancer Res
; 39(8): 4525-4532, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31366555
19.
Prognostic Factors for Pancreatic Cancer Patients Treated with Immune-cell Therapy.
Anticancer Res
; 38(7): 4353-4360, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29970573
20.
Comprehensive immunotherapy combined with intratumoral injection of zoledronate-pulsed dendritic cells, intravenous adoptive activated T lymphocyte and gemcitabine in unresectable locally advanced pancreatic carcinoma: a phase I/II trial.
Oncotarget
; 9(2): 2838-2847, 2018 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29416816